Skip to content

Anaphase-promoting complex subunit 5 (ANAPC5)

Homo sapiens — UniProt Q9UJX4

Gene: ANAPC5Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Anaphase-promoting complex subunit 5 (ANAPC5) is a protein from Homo sapiens identified by UniProt accession Q9UJX4, 755 residues long. MolForge cross-references it against 0 known binders and 51 disease associations.

  • UniProt accession: Q9UJX4; gene symbol ANAPC5.
  • Organism: Homo sapiens.
  • Length: 755 amino acids.
  • Top disease associations (Open Targets): neurodegenerative disease, breast adenocarcinoma and ovarian cancer.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameAnaphase-promoting complex subunit 5
UniProt accessionQ9UJX4
GeneANAPC5
OrganismHomo sapiens
Length755 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (51)

Diseases linked to this target (Open Targets).

  • neurodegenerative disease · score 0.37
  • breast adenocarcinoma · score 0.25
  • ovarian cancer · score 0.23
  • diastolic blood pressure · score 0.19
  • clear cell renal carcinoma · score 0.18
  • endometrial cancer · score 0.18
  • lung adenocarcinoma · score 0.18
  • body height · score 0.18
  • lymphocyte percentage of leukocytes · score 0.18
  • lymphocyte count · score 0.16

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q9UJX4-F1alphafoldPREDICTED81.64—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q9UJX4.

Amino-acid sequence (755 residues)

MASVHESLYF NPMMTNGVVH ANVFGIKDWV TPYKIAVLVL LNEMSRTGEG AVSLMERRRL NQLLLPLLQG PDITLSKLYK LIEESCPQLA NSVQIRIKLM AEGELKDMEQ FFDDLSDSFS GTEPEVHKTS VVGLFLRHMI LAYSKLSFSQ VFKLYTALQQ YFQNGEKKTV EDADMELTSR DEGERKMEKE ELDVSVREEE VSCSGPLSQK QAEFFLSQQA SLLKNDETKA LTPASLQKEL NNLLKFNPDF AEAHYLSYLN NLRVQDVFSS THSLLHYFDR LILTGAESKS NGEEGYGRSL RYAALNLAAL HCRFGHYQQA ELALQEAIRI AQESNDHVCL QHCLSWLYVL GQKRSDSYVL LEHSVKKAVH FGLPYLASLG IQSLVQQRAF AGKTANKLMD ALKDSDLLHW KHSLSELIDI SIAQKTAIWR LYGRSTMALQ QAQMLLSMNS LEAVNAGVQQ NNTESFAVAL CHLAELHAEQ GCFAAASEVL KHLKERFPPN SQHAQLWMLC DQKIQFDRAM NDGKYHLADS LVTGITALNS IEGVYRKAVV LQAQNQMSEA HKLLQKLLVH CQKLKNTEMV ISVLLSVAEL YWRSSSPTIA LPMLLQALAL SKEYRLQYLA SETVLNLAFA QLILGIPEQA LSLLHMAIEP ILADGAILDK GRAMFLVAKC QVASAASYDQ PKKAEALEAA IENLNEAKNY FAKVDCKERI RDVVYFQARL YHTLGKTQER NRCAMLFRQL HQELPSHGVP LINHL

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with ANAPC5?

The strongest Open Targets associations for ANAPC5 are neurodegenerative disease, breast adenocarcinoma, ovarian cancer, diastolic blood pressure and clear cell renal carcinoma.

How long is the ANAPC5 protein?

The Homo sapiens ANAPC5 protein (UniProt Q9UJX4) is 755 amino acids long.

Browse: Targets: A · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Anaphase-promoting complex subunit 5 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ9UJX4
GeneANAPC5
OrganismHomo sapiens
Length755
Binders0
Diseases51
View on UniProt